Qiagen N.V. (QGEN)
NYSE: QGEN · Real-Time Price · USD
55.66
+0.21 (0.38%)
At close: Jan 21, 2026, 4:00 PM EST
55.00
-0.66 (-1.19%)
After-hours: Jan 21, 2026, 7:37 PM EST
Qiagen Employees
Qiagen had 5,967 employees as of December 31, 2023. The number of employees decreased by 211 or -3.42% compared to the previous year.
Employees
5,967
Change (1Y)
-211
Growth (1Y)
-3.42%
Revenue / Employee
$347,039
Profits / Employee
$67,936
Market Cap
11.47B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2023 | 5,967 | -211 | -3.42% |
| Dec 31, 2022 | 6,178 | 150 | 2.49% |
| Dec 31, 2021 | 6,028 | 418 | 7.45% |
| Dec 31, 2020 | 5,610 | 514 | 10.09% |
| Dec 31, 2019 | 5,096 | 144 | 2.91% |
| Dec 31, 2018 | 4,952 | 264 | 5.63% |
| Dec 31, 2017 | 4,688 | 4 | 0.09% |
| Dec 31, 2016 | 4,684 | 125 | 2.74% |
| Dec 31, 2015 | 4,559 | 220 | 5.07% |
| Dec 31, 2014 | 4,339 | 324 | 8.07% |
| Dec 31, 2013 | 4,015 | 16 | 0.40% |
| Dec 31, 2012 | 3,999 | 61 | 1.55% |
| Dec 31, 2011 | 3,938 | 351 | 9.79% |
| Dec 31, 2010 | 3,587 | 92 | 2.63% |
| Dec 31, 2009 | 3,495 | 454 | 14.93% |
| Dec 31, 2008 | 3,041 | 379 | 14.24% |
| Dec 31, 2007 | 2,662 | 708 | 36.23% |
| Dec 31, 2006 | 1,954 | 365 | 22.97% |
| Dec 31, 2005 | 1,589 | 267 | 20.20% |
| Dec 31, 2004 | 1,322 | -231 | -14.87% |
| Dec 31, 2003 | 1,553 | -98 | -5.94% |
| Dec 31, 2002 | 1,651 | 94 | 6.04% |
| Dec 31, 2001 | 1,557 | 242 | 18.40% |
| Dec 31, 2000 | 1,315 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
QGEN News
- 16 hours ago - Qiagen Explores Possible Sale After New Buyer Talks: Report - Benzinga
- 1 day ago - Qiagen weighing strategic options amid fresh takeover interest, Bloomberg reports - Reuters
- 2 days ago - QIAGEN N.V. to Release Results for Q4 2025 and Hold Webcast - Business Wire
- 8 days ago - Qiagen N.V. (QGEN) Presents at 44th Annual J.P. - Seeking Alpha
- 9 days ago - QIAGEN Sets 2026 Priorities to Drive Growth Across Five Pillars Toward Achieving 2028 Goals for Solid Profitable Growth - Business Wire
- 4 weeks ago - QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Million - Business Wire
- 7 weeks ago - Qiagen N.V. (QGEN) Presents at Evercore 8th Annual Healthcare Conference Transcript - Seeking Alpha
- 7 weeks ago - Qiagen N.V. (QGEN) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha